Chronic Obstructive Pulmonary Disease Treatment and Pharmacist-Led Medication Management-Reference-Cited by-同舟云学术

Chronic Obstructive Pulmonary Disease Treatment and Pharmacist-Led Medication Management

Published:2021-01 Issue: Volume:Volume 15 Page:111-124
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Li Liu-Cheng,Han Yong-Yue,Zhang Zhi-Hui,Zhou Wen-Cheng,Fang Hong-Mei,Qu Jiao,Kan Lian-Di^ORCID

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference125 articles.

Hesperetin-5,7,3ʹ-O-Trimethylether Dually Inhibits Phosphodiesterase 3/4 and Methacholine-Induced Airway Hyperresponsiveness in Sensitized and Challenged Mice

2. Trends in burden of chronic obstructive pulmonary disease in Iran, 1995–2015: findings from the global burden of disease study

3. Chronic Obstructive Pulmonary Disease Committee, Respiratory Society, Chinese Medical Association. Guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease (2013 revision). Chin J Tuberc Respir Dis. 2013;36(4):255–264.

Therapeutic potential of BLT1 antagonist for COPD: involvement of inducing autophagy and ameliorating inflammation

5. Understanding the relationships between environmental factors and exacerbations of COPD

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Care pathways versus usual care for chronic obstructive pulmonary disease (COPD);Cochrane Database of Systematic Reviews;2024-08-14

2. Lijing-Anfei Decoction Attenuates COPD  in a Mouse Model: Network Pharmacology  Analysis, Molecular Docking,  and Experimental Validation;Pharmacognosy Magazine;2024-05-28

3. Emerging drug delivery systems with traditional routes – A roadmap to chronic inflammatory diseases;Advanced Drug Delivery Reviews;2023-12

4. Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression;International Journal of Chronic Obstructive Pulmonary Disease;2023-04

5. Gut Microbiome as a Possible Cause of Occurrence and Therapeutic Target in Chronic Obstructive Pulmonary Disease;Journal of Microbiology and Biotechnology;2023-03-30